Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunder Biomedical Tech CoROCO:4115 +1.34%58 Days Payable is 23.68 as of Jun. 2026, which is 2% above its 10-year median of 23.16. GuruFocus rates ROCO:4115 with a GF Score™ of 58/100 and a GF Value™ of NT$9.39 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Sunder Biomedical Tech Co ranks worse than 92.07% on this metric.
The historical rank and industry rank for Sunder Biomedical Tech Co's Days Payable or its related term are showing as below:
ROCO:4115'
s Days Payable Range Over the Past 10 Years
Min: 21.49 Med: 23.16 Max: 27.29
Current: 21.82
During the past 8 years, Sunder Biomedical Tech Co's highest Days Payable was 27.29. The lowest was 21.49. And the median was 23.16.
ROCO:4115's Days Payable is ranked worse than 92.07% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.505
vs ROCO:4115: 21.82
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4115 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Sunder Biomedical Tech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunder Biomedical Tech Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sunder Biomedical Tech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Sunder Biomedical Tech Co's Days Payable falls into.
Sunder Biomedical Tech Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sunder Biomedical Tech Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunder Biomedical Tech Co (ROCO:4115) has a Days Payable of 23.68 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sunder Biomedical Tech Co and its competitors. This is near median its historical median of 23.16. Over the past decade, Sunder Biomedical Tech Co's Days Payable has ranged from 21.49 to 27.29. According to the industry distribution chart, Sunder Biomedical Tech Co ranks #731 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 92.1%.
Is Sunder Biomedical Tech Co's Days Payable too high?
Sunder Biomedical Tech Co's current Days Payable of 23.68 is near median its 10-year median of 23.16. Over the past 10 years, this metric has ranged from a low of 21.49 to a high of 27.29. The Medical Devices & Instruments industry median Days Payable is 68.51. Sunder Biomedical Tech Co's value of 23.68 is 65.4% below this industry median. Based on the distribution chart, Sunder Biomedical Tech Co ranks #731 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sunder Biomedical Tech Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sunder Biomedical Tech Co ranks #731 out of 794 companies for Days Payable. This places Sunder Biomedical Tech Co in the lower half of its industry. The industry median Days Payable is 68.51. Sunder Biomedical Tech Co's value of 23.68 is 65.4% below this benchmark. Historically, Sunder Biomedical Tech Co's own Days Payable has ranged from 21.49 to 27.29 over the past decade. While the company's 10-year median is 23.16 vs. the industry median of 68.51, Sunder Biomedical Tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.51, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunder Biomedical Tech Co's current Days Payable of 23.68 is 65.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sunder Biomedical Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunder Biomedical Tech Co's current Days Payable is 23.68, which is near median its own 10-year median of 23.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$9.39, compared to a current price of NT$7.57 — trading 19.4% below its estimated fair value. The current Days Payable is 23.68, which is near median its 10-year median of 23.16 and 65.4% below the Medical Devices & Instruments industry median of 68.51. Sunder Biomedical Tech Co's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current Days Payable is 23.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued.
The current stock price of NT$7.57 is trading 19.4% below its estimated GF Value™ of NT$9.39.
GuruFocus considers Sunder Biomedical Tech Co to be Modestly Undervalued.
Key valuation signals for ROCO:4115:
Days Payable: 23.68 (near median its 10-year median of 23.16)
GF Value™: NT$9.39 vs. price of NT$7.57 (19.4% below fair value)
Industry Position: 65.4% below the Medical Devices & Instruments median (#731 of 794)
No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
58GF Score
Get the complete analysis for ROCO:4115
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4115 has been successfully added to your 
